Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2

Abstract Objectives Cholangiocarcinoma (CCA) is a rare tumor with a poor prognosis and poses significant therapeutic challenges. Herein, we investigated the mechanism of efficacy of 125I seed implantation therapy in CCA, focusing on the induction of reactive oxygen species (ROS)-mediated apoptosis a...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Luo, Zheng Yao, Weiren Liang, Danjun Song, Hui Zeng, Yi Jiang, Zhehan Bao, Jiaping Zheng, Yinan Ding
Format: Article
Language:English
Published: Springer 2024-06-01
Series:Journal of Cancer Research and Clinical Oncology
Subjects:
Online Access:https://doi.org/10.1007/s00432-024-05840-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863447723442176
author Jun Luo
Zheng Yao
Weiren Liang
Danjun Song
Hui Zeng
Yi Jiang
Zhehan Bao
Jiaping Zheng
Yinan Ding
author_facet Jun Luo
Zheng Yao
Weiren Liang
Danjun Song
Hui Zeng
Yi Jiang
Zhehan Bao
Jiaping Zheng
Yinan Ding
author_sort Jun Luo
collection DOAJ
description Abstract Objectives Cholangiocarcinoma (CCA) is a rare tumor with a poor prognosis and poses significant therapeutic challenges. Herein, we investigated the mechanism of efficacy of 125I seed implantation therapy in CCA, focusing on the induction of reactive oxygen species (ROS)-mediated apoptosis and the involvement of glutathione peroxidase 2 (GPX2). Materials and methods Human cholangiocarcinoma cell lines QBC939 and RBE were purchased for in vitro studies. In vivo studies were performed using a rabbit VX2 CCA model. Apoptosis and proliferation were detected by TUNEL staining and clone formation, respectively. ROS generation was detected by dihydroethidium staining. Histological evaluation was performed by hematoxylin and eosin staining. Protein expression was determined by Western blotting and immunohistochemistry. Results Our results demonstrate that 125I seeds effectively inhibited tumor growth in the rabbit VX2 tumor model and promoted the apoptosis of CCA cells in vitro in a dose-dependent manner. Molecular analyses indicate a marked increase in reactive oxygen species (ROS) levels following treatment with 125I seeds, suggesting the involvement of ROS-mediated apoptosis in the therapeutic mechanism. Furthermore, the downregulation of glutathione peroxidase 2 (GPX2) was observed, indicating its potential role in modulating ROS-mediated apoptosis in CCA. Conclusion 125I seed implantation therapy exerts therapeutic effects on CCA by inducing ROS-mediated apoptosis. The downregulation of GPX2 may contribute to enhanced ROS accumulation and apoptotic cell death. These findings provide mechanistic insights into the therapeutic potential of 125I seed implantation for CCA and highlight ROS-mediated apoptosis and GPX2 regulation as promising targets for further investigation and therapeutic intervention in this malignancy.
format Article
id doaj-art-f60e4c3f61074da89a054bc44252acb1
institution Kabale University
issn 1432-1335
language English
publishDate 2024-06-01
publisher Springer
record_format Article
series Journal of Cancer Research and Clinical Oncology
spelling doaj-art-f60e4c3f61074da89a054bc44252acb12025-02-09T12:10:02ZengSpringerJournal of Cancer Research and Clinical Oncology1432-13352024-06-01150611010.1007/s00432-024-05840-0Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2Jun Luo0Zheng Yao1Weiren Liang2Danjun Song3Hui Zeng4Yi Jiang5Zhehan Bao6Jiaping Zheng7Yinan Ding8Department of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineDepartment of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineDepartment of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineDepartment of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineDepartment of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineDepartment of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineDepartment of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineDepartment of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineDepartment of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Key Laboratory of Imaging and Interventional MedicineAbstract Objectives Cholangiocarcinoma (CCA) is a rare tumor with a poor prognosis and poses significant therapeutic challenges. Herein, we investigated the mechanism of efficacy of 125I seed implantation therapy in CCA, focusing on the induction of reactive oxygen species (ROS)-mediated apoptosis and the involvement of glutathione peroxidase 2 (GPX2). Materials and methods Human cholangiocarcinoma cell lines QBC939 and RBE were purchased for in vitro studies. In vivo studies were performed using a rabbit VX2 CCA model. Apoptosis and proliferation were detected by TUNEL staining and clone formation, respectively. ROS generation was detected by dihydroethidium staining. Histological evaluation was performed by hematoxylin and eosin staining. Protein expression was determined by Western blotting and immunohistochemistry. Results Our results demonstrate that 125I seeds effectively inhibited tumor growth in the rabbit VX2 tumor model and promoted the apoptosis of CCA cells in vitro in a dose-dependent manner. Molecular analyses indicate a marked increase in reactive oxygen species (ROS) levels following treatment with 125I seeds, suggesting the involvement of ROS-mediated apoptosis in the therapeutic mechanism. Furthermore, the downregulation of glutathione peroxidase 2 (GPX2) was observed, indicating its potential role in modulating ROS-mediated apoptosis in CCA. Conclusion 125I seed implantation therapy exerts therapeutic effects on CCA by inducing ROS-mediated apoptosis. The downregulation of GPX2 may contribute to enhanced ROS accumulation and apoptotic cell death. These findings provide mechanistic insights into the therapeutic potential of 125I seed implantation for CCA and highlight ROS-mediated apoptosis and GPX2 regulation as promising targets for further investigation and therapeutic intervention in this malignancy.https://doi.org/10.1007/s00432-024-05840-0125I seedsCholangiocarcinomaROS-mediated apoptosisGPX2
spellingShingle Jun Luo
Zheng Yao
Weiren Liang
Danjun Song
Hui Zeng
Yi Jiang
Zhehan Bao
Jiaping Zheng
Yinan Ding
Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2
Journal of Cancer Research and Clinical Oncology
125I seeds
Cholangiocarcinoma
ROS-mediated apoptosis
GPX2
title Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2
title_full Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2
title_fullStr Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2
title_full_unstemmed Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2
title_short Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2
title_sort mechanistic insights into 125i seed implantation therapy for cholangiocarcinoma focus on ros mediated apoptosis and the role of gpx2
topic 125I seeds
Cholangiocarcinoma
ROS-mediated apoptosis
GPX2
url https://doi.org/10.1007/s00432-024-05840-0
work_keys_str_mv AT junluo mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2
AT zhengyao mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2
AT weirenliang mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2
AT danjunsong mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2
AT huizeng mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2
AT yijiang mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2
AT zhehanbao mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2
AT jiapingzheng mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2
AT yinanding mechanisticinsightsinto125iseedimplantationtherapyforcholangiocarcinomafocusonrosmediatedapoptosisandtheroleofgpx2